Yes, GLP-1 medications like semaglutide and tirzepatide are peptides: short chains of amino acids that act as signaling molecules. But when wellness clinics talk about “peptide therapy,” they usually mean something different: a broad group of therapies with very different levels of evidence and regulatory status. GLP-1s are FDA-approved medications backed by large clinical trials. Many other peptides aren’t, and knowing the difference matters for your safety.
If you’ve been confused about whether GLP-1s and peptide therapy are the same thing, here’s the plain-language breakdown.
What is a peptide?
A peptide is a short chain of amino acids, typically 2 to 50 long. Proteins are the same building blocks in much longer chains. Your body makes many peptides on its own and uses them as messengers, telling cells to release hormones, repair tissue, or regulate appetite. Insulin is a well-known example.
Why GLP-1 medications are peptides
GLP-1 (glucagon-like peptide-1) is a peptide hormone your gut releases after you eat. It helps regulate blood sugar and appetite. The natural version is about 30 amino acids long and breaks down in the bloodstream in under a minute, making it useless as a medication on its own.
Drug makers solved this by engineering longer-lasting versions. The first came from a peptide found in Gila monster venom, and modern medications like semaglutide and tirzepatide are further refined versions that last long enough for weekly dosing. They’re still peptides, just modified ones.
What people usually mean by “peptide therapy”
In wellness and longevity medicine, “peptide therapy” is an umbrella term. It typically refers to peptides prescribed for goals like recovery, body composition, growth hormone support, or sexual wellness. Examples include sermorelin and tesamorelin, which signal the pituitary gland, and PT-141, which supports desire.
Two things are worth knowing:
- Some are approved for one use and prescribed for others. Tesamorelin is FDA-approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, and PT-141 is FDA-approved for low desire in premenopausal women. Other uses are considered off-label.
- Not everything grouped with peptides is a peptide. NAD+, for example, is a coenzyme, not a peptide.
GLP-1 medications vs. other peptide therapies
|
GLP-1 medications
|
Other wellness peptides
|
|
What they are
|
Engineered GLP-1 peptides (semaglutide, tirzepatide)
|
A wide variety of peptides with different goals
|
|
FDA status
|
FDA-approved brands exist for diabetes and weight management
|
Varies: some approved for one use, many used off-label or compounded
|
|
Evidence
|
Large clinical trials
|
Varies widely, often smaller or earlier-stage studies
|
|
Typical goal
|
Appetite, blood sugar, weight
|
Recovery, body composition, energy, sexual wellness, longevity
|
|
How prescribed
|
Licensed provider, individualized titration
|
Licensed provider, individualized plan and monitoring
|
Why the difference matters for safety
Calling everything “peptides” makes it easy to assume they all carry the same safety record. They don’t. FDA-approved GLP-1s have extensive trial data behind them. Many other peptides don’t, which is why screening, informed consent, and monitoring matter even more.
It also matters where your peptide comes from. The World Health Organization has warned about counterfeit GLP-1 products, and U.S. Customs and Border Protection recently intercepted thousands of mislabeled peptide shipments in a single operation. Products sold online as “research use only,” often alongside dosing instructions, are a red flag. We cover this in more detail in our post on whether it’s safe to buy peptides online.
Can you use a GLP-1 and another peptide together?
Sometimes, with provider guidance. Combinations depend on your history, labs, goals, and medications. We typically change one thing at a time so we can tell what’s working and what isn’t.
Questions to ask about any peptide
- Is it FDA-approved, and for what use?
- What evidence supports using it for my goal?
- Which licensed pharmacy prepares it?
- How will my response and safety be monitored?
A provider who can clearly answer all four questions is providing real medical care.
FAQs
Is semaglutide a peptide?
Yes. Semaglutide is an engineered GLP-1 peptide, modified to last long enough for weekly dosing.
Is tirzepatide a peptide?
Yes. Tirzepatide is also a peptide that activates two receptor pathways: GLP-1 and GIP.
Are all peptide therapies FDA-approved?
No. Some peptides are approved for specific conditions, while others are compounded or used off-label with informed consent.
Is NAD+ a peptide?
No. NAD+ is a coenzyme found in every cell. It’s often offered alongside peptide programs but is a different kind of molecule.
Are GLP-1s safer than other peptides?
FDA-approved GLP-1s have far more clinical trial evidence behind them, but they still have side effects and aren’t right for everyone. A licensed provider should prescribe and monitor any peptide.
The bottom line
GLP-1s are peptides, but “GLP-1” and “peptide therapy” aren’t interchangeable terms. One is a specific class of well-studied, FDA-approved medications. The other is a broad category with uneven evidence. The most useful question isn’t “is it a peptide?” but “what is it approved for, what does the evidence show, and who is monitoring me?”
Not sure which option, if any, fits your goals? Schedule a consultation with TBTotal.Health and get an honest answer.
Weight loss and peptide therapies should only be prescribed and monitored by licensed medical providers. Individual results vary. Semaglutide and tirzepatide are FDA-approved in certain branded products. Compounded formulations may be prescribed when an FDA-approved option is not available or clinically appropriate, and other peptides discussed may be FDA-approved for specific uses only, compounded, or used off-label with informed consent.
